/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/4843x1496/b9b684dbb2/eapc-acronym-name-rgb.png)
Clinical application of the new cardiovascular risk prediction algorithms SCORE2 and SCORE2-OP in patients with dyslipidemia
Event: ESC Preventive Cardiology 2022
Topic: Scores
Session: ePosters
Blood pressure target attainment according to the recent ESC cardiovascular prevention guidelines
Event: ESC Preventive Cardiology 2022
Topic: Treatment, Other
Session: ePosters
Increased lipoprotein(a) multiplies coronary heart disease risk in patients with familial hypercholesterolemia
Event: ESC Congress 2021 - The Digital Experience
Topic: Lipids
Session: Risk Factors and Prevention ePosters
Statin-associated muscle symptoms in clinical practice: evidence from a 6-year retrospective study
Event: ESC Congress 2021 - The Digital Experience
Topic: Drug therapy
Session: Risk Factors and Prevention ePosters
Residual cardiovascular risk of patients with dyslipidemia receiving multifactorial cardiovascular prevention therapy
Event: ESC Congress 2021 - The Digital Experience
Topic: Lipids
Session: Risk Factors and Prevention ePosters
ESC 365 is supported by
